ArticleAnnals of thoracic medicine
Patients' outcomes during chronic obstructive pulmonary disease exacerbations are associated with the severity score of the Lancet Commission.
Article in Annals of thoracic medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic obstructive pulmonary disease (COPD) exacerbations significantly affect morbidity, mortality, and healthcare costs. The Lancet Commission proposed a severity classification for COPD exacerbations, but its validation has not been performed. This study aims to assess the relationship between exacerbation severity scores, as defined by the Lancet Commission, and patient outcomes, including morbidity and mortality.
methodsA retrospective, single-center study analyzed 240 hospitalized patients with COPD exacerbations from January 2023 to January 2024. Patients were categorized into three severity groups based on the Lancet exacerbation severity scores. Clinical and laboratory parameters, duration of hospitalization, intensive care unit (ICU) admissions, ventilatory support, and 30-day mortality rates were compared.
resultsOur study found that patients with the highest severity scores had significantly lower hemoglobin and hematocrit levels, higher pCO
conclusionThis study is the first to the Lancet Commission's severity classification in COPD exacerbations. Results indicate that this scoring system can effectively identify patients at high risk for poor outcomes. Future prospective studies are necessary to refine severity assessment criteria and incorporate biochemical markers for improved prognostication and management of COPD exacerbations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.